The US FDA has approved UZEDY (risperidone), developed for the treatment of schizophrenia by Israel’s Teva and France’s Medincell. In a Phase 3 human clinical trial, UZEDY demonstrated up to 80% reduction in risk of schizophrenia relapse versus a placebo.
https://en.globes.co.il/en/article-fda-approves-innovative-teva-schizophrenia-drug-1001445160